about
SearCh for humourIstic and Extravagant acroNyms and Thoroughly Inappropriate names For Important Clinical trials (SCIENTIFIC): qualitative and quantitative systematic study.Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone.Positive serum specific IgE has a short half-life in patients with penicillin allergy and reversal does not always indicate tolerance.A Comprehensive Review of Drug-Drug Interactions with Metformin.Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review.Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study.Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics.Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects.Limited sampling strategy for determining metformin area under the plasma concentration-time curve.Generic switching of warfarin and risk of excessive anticoagulation: a Danish nationwide cohort study.The potential drug-drug interaction between proton pump inhibitors and warfarin.Early Discontinuation of Metformin in Individuals Treated with Inhibitors of Transporters of Metformin.Carriers of genetic variants in the HNF1A gene are more common among dead opioid addicts than among living addicts.Erratum to: Carriers of genetic variants in the HNF1A gene are more common among dead opioid addicts than among living addicts.Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial.A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin.Initiation of glucose-lowering treatment decreases international normalized ratio levels among users of vitamin K antagonists: a self-controlled register study.Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.Microdialysis as a tool to determine the local tissue concentration of dicloxacillin in man.Change in International Normalized Ratio Among Patients Treated With Dicloxacillin and Vitamin K Antagonists.Pharmacokinetics of metformin in patients with gastrointestinal intolerance.Impaired Glucose Tolerance in Healthy Men Treated with St. John's Wort.The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes.A twin study of the trough plasma steady-state concentration of metforminCYP2C19*17increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrelThe role of genetic variants in CYP2C8, LPIN1, PPARGC1A and PPARγ on the trough steady-state plasma concentrations of rosiglitazone and on glycosylated haemoglobin A1c in type 2 diabetesSteady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteersUse of Dicloxacillin and Risk of Pregnancy among Users of Oral ContraceptivesUsing a semi-mechanistic model to identify the main sources of variability of metformin pharmacokineticsThe Effect of Flucloxacillin on Warfarin Anticoagulation: A Swedish Register-Based Nationwide Cohort Study
P50
Q34710448-7F758CD8-DDEB-4B3C-AC39-1A8996DE72C9Q35023736-85A84EAD-E270-46A0-8A67-7563532CD2B2Q35519510-4EDEC69A-A819-4DC6-A95A-900E1D17D4E0Q38460322-3147710A-FA73-42CC-BF39-C7EE5C542F1FQ38726616-A6ACF7C5-0EEF-4C02-8554-CC4DCC594F83Q38948699-D27DAC60-E535-4A31-9EE7-1FF1E65DEADCQ39034109-72190249-34A8-42F6-A0E4-CE9C045F9547Q39221329-C55AF301-00A8-4B4F-BDA9-1ECAB769066DQ39669192-92282817-B380-41B0-8BF1-9BAFC15C3F93Q40179302-566276D8-9F4B-4A9B-AFD6-3BB03C97C025Q40512836-759032C3-D2D7-40EB-9001-222891915C8DQ40775948-EF6AC6D2-6ABB-46CD-8FD6-4EACBE4568A0Q44337607-EDFF3372-F593-474D-8CB9-09446E911BFDQ44341195-5F6FDE06-A062-4842-B812-6176FE433877Q45718198-01FBB544-E37C-4886-89FD-CB92D2283A27Q45892306-811111BF-4870-47F7-BEEF-F8ADD7A4B0C4Q48106202-B8121C59-246B-446B-B561-2883703674FEQ48360626-3543AF60-2D21-485D-A3E1-A38EB497C827Q48361003-C2A25E53-4638-4CA3-82B6-B24CA764049AQ48985099-9BE44C8C-ADFC-4ABA-AD7D-676C48F3B6FAQ49850150-D53E61B1-C5B4-4E86-A7CC-01654D37066FQ53359338-BAC2E5CA-DA76-4637-8168-7D4D64CFDB10Q53728238-AA7357D4-602E-4C57-9FE7-D143624AB761Q53830258-D5BDAF1C-F623-46C1-98E1-3FD408220496Q58301148-433BD9AE-7BEC-40A9-8F51-AA5819D84D5DQ60705776-A46EC765-7754-4496-AE4B-61E91243B795Q60705784-7634F27D-5C0B-41EE-9EC0-1C136B8A53FAQ87240112-415E580E-FD3D-40B0-8147-7EECD3E93474Q87960605-C2D47843-9B6C-4044-9CB3-C729DB74F3FFQ91866229-57F7D15E-2EDA-4ED1-9417-C47B81DAA146Q92227486-382EC386-91EE-44FD-A1F7-08AEB0CC65C4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tore Bjerregaard Stage
@ast
Tore Bjerregaard Stage
@en
Tore Bjerregaard Stage
@es
Tore Bjerregaard Stage
@nl
Tore Bjerregaard Stage
@sl
type
label
Tore Bjerregaard Stage
@ast
Tore Bjerregaard Stage
@en
Tore Bjerregaard Stage
@es
Tore Bjerregaard Stage
@nl
Tore Bjerregaard Stage
@sl
prefLabel
Tore Bjerregaard Stage
@ast
Tore Bjerregaard Stage
@en
Tore Bjerregaard Stage
@es
Tore Bjerregaard Stage
@nl
Tore Bjerregaard Stage
@sl
P106
P31
P496
0000-0002-4698-4389